Scope of the Report
The report titled “Global Injectable Drug Market: Size, Trends and Forecasts (2016-2020)” provides an in-depth analysis of the global injectable market with detailed analysis of the actual and the expected market size along with the market size of each market segment.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global injectable drug market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global injectable drug market is stiff and dominated by the big players like Pfizer, Inc. Further, key players of the injectable drug market such as Merck & Co., Inc., Novartis AG and Johnson & Johnson are also profiled with their financial information and respective business strategies.
Regional Coverage
- Global
Company Coverage
- Pfizer, Inc.
- Merck & Co., Inc.
- Novartis AG
- Johnson & Johnson
Executive Summary
Injectable drugs are the drugs which are introduced into the body with a hollow needle and a syringe which is pierced through the skin into the body. Injections are among the most common health care procedures, with at least 16 billion administered in developing and transitional countries each year.
The global injectable drug market has increased at a significant CAGR during 2012-2015 and projections are made that the market would rise tremendously in the next five years i.e. 2016-2020. The growth in the market is driven by patient awareness, increase in per capita drug spending, a rise in the personal disposable income of individuals and etc. The market can be segmented into vaccines, insulin, conventional therapeutics and complex biologics. Of all the segments, complex biologics remains the largest segment of the market with the highest growth rate.
The major growth drivers for the injectable drug market are: rise in cancer incidences & diabetic population, the introduction of new products and increase in biologics & new drugs license approvals. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as high risk of re-operation or death, injectable drug safety issues and less patient compliance.
Tags :
1. Executive Summary
2. Introduction
2.1 Introduction to Injectable Drugs
2.2 Types of Injectable Drugs
2.3 Types of Injectable Routes
3. Global Market Analysis
3.1 Global Injectable Drug Market by Value
3.2 Global Injectable Drug Market by Segments
3.2.1 Global Injectable Vaccine Market by Value
3.2.2 Global Injectable Insulin Market by Value
3.2.3 Global Injectable Conventional Therapeutics Market by Value
3.2.4 Global Injectable Complex Biologics Market by Value
3.3 Global Injectable Drug Market as a Share of Total Drug Market
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increase in Cancer Incidences
4.1.2 Rise in Diabetic Population
4.1.3 Introduction of New Products
4.1.4 Increase in Biologics and New Drugs License Approvals
4.2 Challenges
4.2.1 High Risk of Re-operation or Death
4.2.2 Injectable Drug Safety Issues
4.2.3 Less Patient Compliance
4.3 Market Trends
4.3.1 Technological Innovations in the Global Injectable Delivery Market
4.3.2 Evolution of Combination Products
4.3.3 Injectable Drugs Packaging
4.3.4 Flexible Manufacturing
4.3.5 Biosimilars
5. Competitive Landscape
5.1 Pharmaceutical Companies Ranking
5.2 Pharmaceutical Companies Brand Value
6. Company Profiling
6.1 Pfizer, Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.2 Merck & Co., Inc.
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy
6.3 Novartis AG
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy
6.4 Johnson & Johnson
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategy
Figure 1: Types of Injectable Drugs
Figure 2: Types of Injectable Routes
Figure 3: Global Injectable Market by Value; 2012-2015 (US$ Billion)
Figure 4: Global Injectable Market by Value; 2016E-2020E (US$ Billion)
Figure 5: Global Injectable Market by Segments; 2015 (%)
Figure 6: Global Injectable Vaccine Market by Value; 2012-2020E (US$ Billion)
Figure 7: Global Injectable Insulin Market by Value; 2012-2020E (US$ Billion)
Figure 8: Global Injectable Conventional Therapeutic Market by Value; 2012-2020E (US$ Billion)
Figure 9: Global Injectable Complex Biologics Market by Value; 2012-2020E (US$ Billion)
Figure 10: Global Injectable Drug Market as a Share of Total Drug Market; 2013 (%)
Figure 11: Global Cancer Incidences; 2012-2020E (Million)
Figure 12: Global Diabetic Population; 2011-2040E (Million)
Figure 13: Global New Injectable Drug Market by Value; 2012-2020E (US$ Billion)
Figure 14: FDA Approvals for Biologics and New Drugs License Applications; 2013-2015
Figure 15: Top 10 Pharmaceutical Companies Brand Value; 2016 (US$ Billion)
Figure 16: Pfizer, Inc. Total Revenues; 2011-2015 (US$ Billion)
Figure 17: Pfizer, Inc. Revenues by Segments; 2015 (%)
Figure18: Pfizer, Inc. Revenues by Region; 2015 (%)
Figure 19: Merck & Co., Inc. Total Sales; 2011-2015 (US$ Billion)
Figure 20: Merck & Co., Inc. Sales by Segments; 2015 (%)
Figure 21: Merck & Co., Inc. Sales by Region; 2015 (%)
Figure 22: Novartis AG Business Segments
Figure 23: Novartis AG Total Sales; 2011-2015 (US$ Billion)
Figure 24: Novartis AG Sales by Segments; 2015 (%)
Figure 25: Novartis AG Sales by Region; 2015 (%)
Figure 26: Johnson & Johnson Total Sales; 2011-2015 (US$ Billion)
Figure 27: Johnson & Johnson Sales by Segments; 2015 (%)
Figure 28: Johnson & Johnson Sales by Region; 2015 (%)
Table 1:Top 10 Pharmaceutical Companies on the Basis of the Revenues; 2015
